Evangelia Ntzani

Prof. Evangelia Ntzani

Department of Hygiene and Epidemiology
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2018 in Nature Genetics
Verified
Journal Article
Open access
2T23andMe Research Team
23andMe Research Team
JMJohn A. Morris
John A. Morris
JKJohn P. Kemp
John P. Kemp
SYScott E. Youlten
Scott E. Youlten
LLLaetitia Laurent
Laetitia Laurent
JRJ. Brent Richards
J. Brent Richards
Osteoporosis is a common aging-related disease diagnosed primarily using bone mineral density (BMD). We assessed genetic determinants of BMD as estimated by heel quantitative ultrasound in 426,824 individuals, identifying 518 genome-wide significant loci (301 novel), explaining 20% of its variance. We identified 13 bone fracture loci, all associated with estimated BMD (eBMD), in ~1.2 million individuals. We then identified target genes enriched for genes known to influence bone density and strength (maximum odds ratio (OR) = 58, P = 1 × 10-75) from cell-specific features, including chromatin conformation and accessible chromatin sites. We next performed rapid-throughput skeletal phenotyping of 126 knockout mice with disruptions in predicted target genes and found an increased abnormal skeletal phenotype frequency compared to 526 unselected lines (P < 0.0001). In-depth analysis of one gene, DAAM2, showed a disproportionate decrease in bone strength relative to mineralization. This genetic atlas provides evidence linking associated SNPs to causal genes, offers new insight into osteoporosis pathophysiology, and highlights opportunities for drug development.

1 January 2018 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
KBKonstantinos I Bougioukas
Konstantinos I Bougioukas
ALAris Liakos
Aris Liakos
ATApostolos Tsapas
Apostolos Tsapas
ENEvangelia Ntzani
Evangelia Ntzani
AHAnna-Bettina Haidich
Anna-Bettina Haidich

1 May 2018 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
GNGeorgios Ntritsos
Georgios Ntritsos
JFJacob Franek
Jacob Franek
LBLazaros Belbasis
Lazaros Belbasis
MCMaria A Christou
Maria A Christou
GMGeorgios Markozannes
Georgios Markozannes
EEEvangelos Evangelou
Evangelos Evangelou
Rationale: COPD has been perceived as being a disease of older men. However, >7 million women are estimated to live with COPD in the USA alone. Despite a growing body of literature suggesting an increasing burden of COPD in women, the evidence is limited. Objectives: To assess and synthesize the available evidence among population-based epidemiologic studies and calculate the global prevalence of COPD in men and women. Materials and methods: A systematic review and meta-analysis reporting gender-specific prevalence of COPD was undertaken. Gender-specific prevalence estimates were abstracted from relevant studies. Associated patient characteristics as well as custom variables pertaining to the diagnostic method and other important epidemiologic covariates were also collected. A Bayesian random-effects meta-analysis was performed investigating gender-specific prevalence of COPD stratified by age, geography, calendar time, study setting, diagnostic method, and disease severity. Measurements and main results: Among 194 eligible studies, summary prevalence was 9.23% (95% credible interval [CrI]: 8.16%–10.36%) in men and 6.16% (95% CrI: 5.41%–6.95%) in women. Gender prevalences varied widely by the World Health Organization Global Burden of Disease subregions, with the highest female prevalence found in North America (8.07% vs 7.30%) and in participants in urban settings (13.03% vs 8.34%). Meta-regression indicated that age ≥40 and bronchodilator testing contributed most significantly to heterogeneity of prevalence estimates across studies. Conclusion: We conducted the largest ever systematic review and meta-analysis of global prevalence of COPD and the first large gender-specific review. These results will increase awareness of COPD as a critical woman’s health issue.

12 June 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ASAristeidis Seretis
Aristeidis Seretis
Sofia CividiniSofia Cividini
Sofia Cividini
GMGeorgios Markozannes
Georgios Markozannes
XTXanthippi Tseretopoulou
Xanthippi Tseretopoulou
DLDavid S. Lopez
David S. Lopez
KTKostas Tsilidis
Kostas Tsilidis
With the exception of renal cell carcinoma, studies assessing the association between hypertension and other cancers are inconsistent. We conducted a meta-analysis to assess this evidence. We included observational studies investigating the association between any definition of hypertension or systolic and diastolic blood pressure and risk of any cancer, after searching PubMed until November 2017. We calculated summary relative risks (RR) and 95% confidence intervals (CI) using inverse-variance weighted random effects methods. A total of 148 eligible publications were identified out of 39,891 initially screened citations. Considering only evidence from 85 prospective studies, positive associations were observed between hypertension and kidney, colorectal and breast cancer. Positive associations between hypertension and risk of oesophageal adenocarcinoma and squamous cell carcinoma, liver and endometrial cancer were also observed, but the majority of studies did not perform comprehensive multivariable adjustments. Systolic and diastolic blood pressure were positively associated with risk of kidney cancer but not with other cancers. In addition to the previously well-described association between hypertension and risk of kidney cancer, the current meta-analysis suggested that hypertensive individuals may also be at higher risk of colorectal and breast cancer. However, careful interpretation is required as most meta-analyses included relatively small number of studies, several relative risks had weak or moderate magnitude and maybe affected by residual confounding.

1 September 2021 in Environmental Pollution
Verified
Journal Article
Closed access
MKMaria A. Karalexi
Maria A. Karalexi
CTChristos Fotios Tagkas
Christos Fotios Tagkas
GMGeorgios Markozannes
Georgios Markozannes
XTXanthippi Tseretopoulou
Xanthippi Tseretopoulou
AHAntonio Hernández
Antonio Hernández
ENEvangelia Ntzani
Evangelia Ntzani

6 August 2020 in Eurosurveillance
Verified
Journal Article
Open access
ZBZacharoula Bogogiannidou
Zacharoula Bogogiannidou
AVAlexandros Vontas
Alexandros Vontas
KDKaterina Dadouli
Katerina Dadouli
MKMaria Kyritsi
Maria Kyritsi
SSSoteris Soteriades
Soteris Soteriades
Christos HadjichristodoulouChristos Hadjichristodoulou
Christos Hadjichristodoulou
A serosurvey of IgG antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) was performed during March and April 2020. Among 6,586 leftover sera, 24 (0.36%) were positive, with higher prevalence in females, older individuals and residents of large urban areas. Seroprevalence was estimated at 0.02% and 0.25%, respectively, in March and April, infection fatality rate at 2.66% and 0.54%. Our findings confirm low COVID-19 incidence in Greece and possibly the effectiveness of early measures.